LH:NYSELabcorp Holdings Inc. Analysis

Labcorp (LH) is trading at $259.93, comfortably above its DCF‑derived fair value of $155, indicating the market is pricing in strong growth expectations. The stock sits just below its 20‑day (256.28), 50‑day (263.18) and 200‑day (268.48) SMAs, and the trend indicator flags a bearish bias, while the RSI of 51.4 suggests neutral momentum. A bullish MACD histogram (+0.78) provides a short‑term upside hint, but volume is decreasing, adding uncertainty to any near‑term breakout. Fundamentals are solid: revenue grew 5.8% YoY to $14.14 B, forward EPS of $19.44 reflects a 72% upside from trailing EPS, and the forward P/E of 13.4 is well below the industry average of 27.6. The dividend yield of 1.11% is backed by a modest 25.5% payout ratio and healthy free cash flow, supporting sustainability. Analyst consensus (17 analysts) is a “Buy” with a median price target of $320, implying ~19% upside, while the Fear & Greed Index at 91.6 (“Extreme Greed”) signals strong market optimism. Overall, the stock balances robust earnings momentum and defensive dividend characteristics against a technically bearish backdrop and an elevated market price.